160 related articles for article (PubMed ID: 21734416)
1. Immunochemistry and lung cancer: application in diagnosis, prognosis and targeted therapy.
Nanguzgambo AB; Razack R; Louw M; Bolliger CT
Oncology; 2011; 80(3-4):247-56. PubMed ID: 21734416
[TBL] [Abstract][Full Text] [Related]
2. Biological markers in lung cancer: A clinician's perspective.
Tufman A; Huber RM
Cancer Biomark; 2010; 6(3-4):123-35. PubMed ID: 20660959
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.
Dacic S
Expert Rev Mol Diagn; 2007 Jan; 7(1):77-86. PubMed ID: 17187486
[TBL] [Abstract][Full Text] [Related]
4. Advances in the diagnosis of lung cancer: contribution of molecular biology to bronchoscopic diagnosis.
Maldonado F; Jett JR
Curr Opin Pulm Med; 2010 Jul; 16(4):315-20. PubMed ID: 20173641
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
Bremnes RM; Sirera R; Camps C
Lung Cancer; 2005 Jul; 49(1):1-12. PubMed ID: 15949585
[TBL] [Abstract][Full Text] [Related]
6. Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.
Cho WC
Biomed Pharmacother; 2007 Oct; 61(9):515-9. PubMed ID: 17913444
[TBL] [Abstract][Full Text] [Related]
7. [Molecular staging and prognosis in lung cancer].
Sánchez de Cos Escuín J
Arch Bronconeumol; 2011 Nov; 47(11):539-40. PubMed ID: 21831500
[No Abstract] [Full Text] [Related]
8. Clinical relevance of thymidine kinase for the diagnosis, therapy monitoring and prognosis of non-operable lung cancer.
Holdenrieder S; Von Pawel J; Duell T; Feldmann K; Raith H; Schollen A; Nagel D; Stieber P
Anticancer Res; 2010 May; 30(5):1855-62. PubMed ID: 20592392
[TBL] [Abstract][Full Text] [Related]
9. Translational research in lung cancer.
Chen Y; Okunieff P; Ahrendt SA
Semin Surg Oncol; 2003; 21(3):205-19. PubMed ID: 14508854
[TBL] [Abstract][Full Text] [Related]
10. Expression of Smac/DIABLO is a novel prognostic marker in lung cancer.
Sekimura A; Konishi A; Mizuno K; Kobayashi Y; Sasaki H; Yano M; Fukai I; Fujii Y
Oncol Rep; 2004 Apr; 11(4):797-802. PubMed ID: 15010875
[TBL] [Abstract][Full Text] [Related]
11. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology.
Hirsch FR; Franklin WA; Gazdar AF; Bunn PA
Clin Cancer Res; 2001 Jan; 7(1):5-22. PubMed ID: 11205917
[TBL] [Abstract][Full Text] [Related]
12. The classification of lung carcinoma: time to change the morphology-based approach?
Pelosi G; Sonzogni A; Viale G
Int J Surg Pathol; 2010 Jun; 18(3):161-72. PubMed ID: 20460313
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.
Sher YP; Shih JY; Yang PC; Roffler SR; Chu YW; Wu CW; Yu CL; Peck K
Clin Cancer Res; 2005 Jan; 11(1):173-9. PubMed ID: 15671543
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of tissue polypeptide antigen determination in lung cancer management.
Rapellino M; Pecchio F; Baldi S; Scappaticci E; Cavallo A
Anticancer Res; 1995; 15(3):1065-70. PubMed ID: 7645927
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer: diagnosis and management.
Collins LG; Haines C; Perkel R; Enck RE
Am Fam Physician; 2007 Jan; 75(1):56-63. PubMed ID: 17225705
[TBL] [Abstract][Full Text] [Related]
16. Clinical detection of lung cancer progression markers.
Tockman MS
J Cell Biochem Suppl; 1996; 25():177-84. PubMed ID: 9027616
[TBL] [Abstract][Full Text] [Related]
17. Exhaled breath analysis: novel approach for early detection of lung cancer.
Chan HP; Lewis C; Thomas PS
Lung Cancer; 2009 Feb; 63(2):164-8. PubMed ID: 18599152
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers for lung cancer: clinical uses.
Greenberg AK; Lee MS
Curr Opin Pulm Med; 2007 Jul; 13(4):249-55. PubMed ID: 17534168
[TBL] [Abstract][Full Text] [Related]
19. Circulating apoptotic markers in the management of non-small cell lung cancer.
Holdenrieder S; Stieber P
Cancer Biomark; 2010; 6(3-4):197-210. PubMed ID: 20660965
[TBL] [Abstract][Full Text] [Related]
20. Using molecular markers in sputum for the early detection of lung cancer: a review.
Kennedy TC; Hirsch FR
Lung Cancer; 2004 Aug; 45 Suppl 2():S21-7. PubMed ID: 15552778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
